• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Lumbar Drain Use during Middle Fossa Approaches for Nonneoplastic Pathology of the Skull Base
Conclusion No difference in postoperative outcomes was observed in patients who had an intraoperative LD placed compared to those without LD. Operative times were increased in the LD cohort, but this difference was not statistically significant. Given the similar outcomes, we conclude that LD is not necessary to facilitate safe MCF for nonneoplastic skull base pathologies. [...] Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of contents  |  Abstract  |  Full text
Source: Journal of Neurological Surgery Part B: Skull Base - April 21, 2023 Category: Neurosurgery Authors: Dambrino, Robert J. Wong, Gunther W. Tang, Alan R. Jo, Jacob Yengo-Kahn, Aaron M. Lindquist, Nathan R. Freeman, Michael H. Haynes, David S. Tawfik, Kareem O. Chambless, Lola B. Thompson, Reid C. Morone, Peter J. Tags: Original Article Source Type: research

Risk Factors and the Management of Entrapped Temporal Horn following Lateral Ventricular Tumor Surgery
CONCLUSION: ETH often occurs following the surgery of lateral ventricle tumors. Large tumor diameter, tumor stroke, non-EVD at the end of operation, and the mechanical separation of the tumor boundary are the risk factors of ETH. The natural exposure of the tumor boundary during surgery, avoiding the use of hemostatic materials, placing an EVD tube at the end of operation, and postoperative infection control can effectively reduce the occurrence of ETH. It is essential to select the appropriate treatment method for patients with postoperative ETH.PMID:36482848 | DOI:10.5137/1019-5149.JTN.36722-21.2
Source: Turkish Neurosurgery - December 9, 2022 Category: Neurosurgery Authors: Gaochao Song Jin Yuan Jianhong Shen Zhicheng Zhao Guiping Ni Qi Yao Source Type: research

Prevention of neurological complications during COVID-19: a retrospective analysis of the ISARIC4C national cohort
This study is the first to focus on the prevention of neurological complications and strongly supports the continued use of both dexamethasone and remdesivir in severe COVID-19. Our results suggest that the established benefit of dexamethasone on mortality in COVID-19 is not associated with an increased burden of long-term neurological disability.
Source: Journal of Neurology, Neurosurgery and Psychiatry - August 12, 2022 Category: Neurosurgery Authors: Grundmann, A., Hardwick, M., Wu, C.-H., Semple, M., Böhning, D., Pett, S., Michael, B., Thomas, R., Galea, I. Tags: Parallel Session 4: COVID Wed 18 May, 1445 - 1600 3 Source Type: research

Pages: 1  2  3  4